Gokshura / Tribulus Extract Regulatory & Compliance Guide (EU, US & India)

European Union

In the EU, tribulus extract is handled as a botanical used in food supplements, regulated at member-state level within the EU food-law framework. Three points dominate:

• Health claims. No health claim for tribulus is authorised on the EU Register of nutrition and health claims, and many traditional botanical (“Article 13.1”) claims remain on hold / pending. In practice this means you cannot make an authorised health claim for gokshura in the EU, and testosterone or hormonal claims are firmly outside what is permitted. Structure/function language must be handled with care and checked against national enforcement.
• Contaminant limits. Heavy metals (lead, cadmium, mercury, arsenic) are controlled; extracts must meet the applicable limits with ICP-MS data on the CoA.
• Pesticide MRLs & ethylene oxide (ETO). Indian botanical extracts face increased official controls on entry, with ethylene oxide a recurrent detention cause across the sector. Pre-test pesticide residues against EU MRLs and confirm an ETO-free status before shipping.

Also assess novel-food status for your specific preparation and use level: a traditional food-supplement use of tribulus fruit is generally treated differently from a highly concentrated or non-traditional preparation, and the burden is on the importer to confirm.

United States

In the US, gokshura is marketed as a dietary ingredient under DSHEA. Key points:

• Claims. Only structure/function claims are permitted (e.g. supports vitality/physical performance in general terms), with the standard DSHEA disclaimer and FDA notification. Disease claims and explicit testosterone-boosting claims invite enforcement.
• cGMP. Finished products must be made under 21 CFR 111; your incoming extract should carry identity, potency and contaminant data that support your own GMP file.
• Substantiation. Claims must be truthful and not misleading — the mixed clinical picture on tribulus and testosterone means aggressive performance claims are hard to substantiate. See tribulus saponins & protodioscin for a compliance-safe read of the evidence.

India

In India, gokshura sits within both the Ayurvedic tradition and the modern nutraceutical framework:

• FSSAI regulates nutraceuticals and health supplements, including botanical ingredients and their permitted use levels.
• AYUSH governs classical Ayurvedic products where gokshura is a recognised drug of the Ayurvedic pharmacopoeia.
• For export, align the CoA and claims to the destination market’s rules, which are usually stricter than domestic ones.

The Compliance Documentation Pack

• Batch CoA with saponin assay (method stated), heavy metals by ICP-MS, microbiology and identity.
• Pesticide-residue report against destination MRLs (EU-critical).
• Residual-solvent and ETO statements.
• Allergen, Non-GMO, MSDS and Country-of-Origin declarations.
• Organic certificate where the line is organic-positioned.

For how these documents are produced and requested, see the sourcing guide; for grade selection, the buyer’s guide.

This article is general information for B2B buyers and is not legal or regulatory advice. Requirements change and vary by market and product; verify current rules with a qualified regulatory professional for your destination.